Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
     J05A DIRECT ACTING ANTIVIRALS
       J05AA Thiosemicarbazones
       J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
       J05AC Cyclic amines
       J05AD Phosphonic acid derivatives
       J05AE Protease inhibitors [DG:DG01647]
       J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
       J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
       J05AH Neuraminidase inhibitors [DG:DG02842]
       J05AP Antivirals for treatment of HCV infections
       J05AR Antivirals for treatment of HIV infections, combinations
         J05AR01 Zidovudine and lamivudine
         J05AR02 Lamivudine and abacavir
         J05AR03 Tenofovir disoproxil and emtricitabine
         J05AR04 Zidovudine, lamivudine and abacavir
         J05AR05 Zidovudine, lamivudine and nevirapine
         J05AR06 Emtricitabine, tenofovir disoproxil and efavirenz
         J05AR07 Stavudine, lamivudine and nevirapine
         J05AR08 Emtricitabine, tenofovir disoproxil and rilpivirine
         J05AR09 Emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat
         J05AR10 Lopinavir and ritonavir
         J05AR11 Lamivudine, tenofovir disoproxil and efavirenz
         J05AR12 Lamivudine and tenofovir disoproxil
         J05AR13 Lamivudine, abacavir and dolutegravir
         J05AR14 Darunavir and cobicistat
         J05AR15 Atazanavir and cobicistat
         J05AR16 Lamivudine and raltegravir
           D10754  Lamivudine - raltegravir mixt
         J05AR17 Emtricitabine and tenofoviralafenamide
         J05AR18 Emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat
         J05AR19 Emtricitabine, tenofoviralafenamide and rilpivirine
         J05AR20 Emtricitabine, tenofovir alafenamide and bictegravir
         J05AR21 Dolutegravir and rilpivirine
         J05AR22 Emtricitabine, tenofovir alafenamide, darunavir and cobicistat
         J05AR23 Atazanavir and ritonavir
         J05AR24 Lamivudine, tenofovir disoproxil and doravirine
       J05AX Other antivirals
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 22, 2019
According to WHO's ATC 2019

» Japanese version